# Pentoxifylline and Systemic Inflammation in Hemodialysis Patients

> **NCT01269827** · PHASE4 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 36 (actual)

## Conditions studied

- Inflammation
- End-stage Renal Disease
- Hemodialysis

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** starch tablets

## Key facts

- **NCT ID:** NCT01269827
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269827, "Pentoxifylline and Systemic Inflammation in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01269827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*